Concepedia

Christopher Riling

CR

5

Publications

236

Citations

5

H-Index

2010

Active since

Affiliations

University of Pennsylvania(Current)

Children's Hospital of Philadelphia

Progenra (United States)

Christopher Riling is an author at University of Pennsylvania specializing in cell signaling, autoimmunity, and chronic inflammation.

Top concepts

Publications per year

2010–2021

5

Publications

5

CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies

Kaosheng Lv, Jing Jiang, Ryan Donaghy et al. · Genes & Development · 2017 · 70 citations · Full text

Itch WW Domains Inhibit Its E3 Ubiquitin Ligase Activity by Blocking E2-E3 Ligase Trans-thiolation

Christopher Riling, Hari Kamadurai, Suresh Kumar et al. · Journal of Biological Chemistry · 2015 · 66 citations · Full text

Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates

Helena Costa Verdera, Fanny Collaud, Christopher Riling et al. · Nature Communications · 2021 · 36 citations · Full text

The ubiquitin ligase adaptor Ndfip1 regulates T cell-mediated gastrointestinal inflammation and inflammatory bowel disease susceptibility

Hilda E. Ramón, Christopher Riling, Jonathan P. Bradfield et al. · Mucosal Immunology · 2010 · 33 citations · Full text

, , +9

Ndfip-mediated degradation of Jak1 tunes cytokine signalling to limit expansion of CD4+ effector T cells

Claire E. O’Leary, Christopher Riling, Lynn A. Spruce et al. · Nature Communications · 2016 · 31 citations · Full text

Rows per page

1–5 of 5